<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Scientific Validation | HealthCare Innovation</title>
	<atom:link href="https://healthcareinnovation.tn/experts_tag/scientific-validation/feed/" rel="self" type="application/rss+xml" />
	<link>https://healthcareinnovation.tn</link>
	<description>HealthCare Innovation</description>
	<lastBuildDate>Thu, 30 Oct 2025 15:02:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://healthcareinnovation.tn/wp-content/uploads/2025/05/cropped-Favicons-HealthCare-32x32.webp</url>
	<title>Scientific Validation | HealthCare Innovation</title>
	<link>https://healthcareinnovation.tn</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Dr. Haroun Ouanes</title>
		<link>https://healthcareinnovation.tn/experts/dr-haroun-ouanes/</link>
		
		<dc:creator><![CDATA[healthcareinnovation.com]]></dc:creator>
		<pubDate>Thu, 30 Oct 2025 16:27:03 +0000</pubDate>
				<guid isPermaLink="false">https://healthcareinnovation.tn/?post_type=experts&#038;p=25963740</guid>

					<description><![CDATA[<p>Dr. Haroun Ouanes is a PharmD in Industrial Pharmacy with an Executive MBA from IAE Paris Sorbonne. He is a senior partner at Healthcare Novation and an expert in HealthTech business strategy, innovation ecosystems, and startup incubation. With extensive experience in venture capital, public-private partnerships, and policy advisory, he has led high-impact HealthTech projects in [&#8230;]</p>
<p>L’article <a rel="nofollow" href="https://healthcareinnovation.tn/experts/dr-haroun-ouanes/">Dr. Haroun Ouanes</a> est apparu en premier sur <a rel="nofollow" href="https://healthcareinnovation.tn">HealthCare Innovation</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Dr. Haroun Ouanes is a PharmD in Industrial Pharmacy with an Executive MBA from IAE Paris Sorbonne. He is a senior partner at Healthcare Novation and an <a href="https://healthcareinnovation.tn/experts/">expert</a> in HealthTech business strategy, innovation ecosystems, and startup incubation. With extensive experience in venture capital, public-private partnerships, and policy advisory, he has led high-impact HealthTech projects in Tunisia and internationally. He also serves as a mentor, trainer, and speaker in entrepreneurship programs across Africa, Europe, and the Middle East.</p>
<p>L’article <a rel="nofollow" href="https://healthcareinnovation.tn/experts/dr-haroun-ouanes/">Dr. Haroun Ouanes</a> est apparu en premier sur <a rel="nofollow" href="https://healthcareinnovation.tn">HealthCare Innovation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dr. Mohamed Bejaoui</title>
		<link>https://healthcareinnovation.tn/experts/dr-mohamed-bejaoui/</link>
		
		<dc:creator><![CDATA[healthcareinnovation.com]]></dc:creator>
		<pubDate>Mon, 12 May 2025 15:49:50 +0000</pubDate>
				<guid isPermaLink="false">https://healthcareinnovation.tn/?post_type=experts&#038;p=25963746</guid>

					<description><![CDATA[<p>Dr. Mohamed Bejaoui is an Assistant Professor of Pharmacology at the Faculty of Pharmacy, Monastir, with 15+ years of experience in preclinical studies and biomedical research. Holding a PhD in Pharmaceutical Sciences from the University of Monastir and a PhD in Physiology from the University of Barcelona, his research focuses on hepatic ischemia-reperfusion injury, organ [&#8230;]</p>
<p>L’article <a rel="nofollow" href="https://healthcareinnovation.tn/experts/dr-mohamed-bejaoui/">Dr. Mohamed Bejaoui</a> est apparu en premier sur <a rel="nofollow" href="https://healthcareinnovation.tn">HealthCare Innovation</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Dr. Mohamed Bejaoui is an Assistant Professor of Pharmacology at the <a href="https://healthcareinnovation.tn/institutions/faculty-of-pharmacy-of-monastir/">Faculty of Pharmacy, Monastir</a>, with 15+ years of experience in preclinical studies and biomedical research. Holding a PhD in Pharmaceutical Sciences from the<a href="https://healthcareinnovation.tn/institutions/faculty-of-medicine-of-monastir/"> University of Monastir </a>and a PhD in Physiology from the University of Barcelona, his research focuses on hepatic ischemia-reperfusion injury, organ preservation, drug-excipient interactions, and natural compound identification. He has extensive experience in preclinical animal studies and molecular biology techniques, contributing significantly to pharmacological innovation.</p>
<p>L’article <a rel="nofollow" href="https://healthcareinnovation.tn/experts/dr-mohamed-bejaoui/">Dr. Mohamed Bejaoui</a> est apparu en premier sur <a rel="nofollow" href="https://healthcareinnovation.tn">HealthCare Innovation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
